Alza Corporation

Michael H Dealey

Patrick S Wong

Brian L Barclay

Liang C Dong

Terry L Burkoth

Jerry D Childers

Felix T Theeuwes

Lawrence G Hamel

Si-Hong A Yum

A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.

Method for administering steroid

Dosage form comprising hydrophilic polymer

The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial delay period to startup or activation of the device being of a predetermined length of time. The delivery of the agent formulation from the dispensing device is continued until essentially all of the active agent formulation is delivered as a result of the expansion of an expansion agent in the active agent delivery chamber.

Osmotic device with delayed activation of drug delivery and complete

An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing the beneficial agent from the osmotic system.

Osmotic dosage system for liquid drug delivery

Method for administering drug

Osmotic dosage system for delivering a formulation comprising liquid

Method for administering anti-Parkinson drug

Process for lessening irritation caused by drug

Process for improving dosage form delivery kinetics

Growing community of inventors

San Francisco, CA, United States of America

Michael H Dealey